Model
Edge
Aurinia Pharmaceuticals Inc.
AUPH
Filing Type
8-K
Filing Date
11/6/2024
Updated
11/7/24, 4:13 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Financial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation
EX-99.1
Financial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation
EX-99.2
Financial Results, Costs of Shutting Down or Selling Parts of the Business, Changes in Board, Management or Compensation
GRAPHIC